08.08.23 -- Improve Efficiency And Consistency In Drug Release With Nanoforming

Advances in sustained-release drug delivery could improve efficiency and consistency in drug release, manifesting real-life advantages for patients in the form of enhanced accessibility and compliance.

This poster demonstrates the application of in vitro flux assays to nanoparticles, with data on how the in vitro permeability apparatus can be utilized to characterize the membrane flux performance of an API formulated as a nanosuspension.

Drug lipophilicity is a core property that contributes to drug solubility, permeability, metabolic disposition, and other key properties. Take a deeper look into how drug lipophilicity has evolved over time, its impact on drug development, and the need for new technology to enable new more complex drugs.

The low-hanging fruit of drug development — simple compounds — have mainly been used up, prompting companies to focus on more complex molecules, yet most of these exhibit solubility and bioavailability challenges. Discover how nanoforming drug particles to below 100 nm could help.